Carotid Stent Articles & Analysis
9 news found
Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and Rennes University Hospital, today announce the launch of a co-development research program using robotics to improve treatment for stroke victims. With the support of Philips France, this unique program will be implemented over the next four years. It will focus on the use of ...
ByRobocath
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announces today its successful first robotic carotid stenting at Rennes University Hospital. This breakthrough in the neurovascular field was performed on November 16, using Robocath’s R-One robot, operated by Dr. ...
ByRobocath
(Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced that results from the investigator-initiated SIBERIA randomized clinical trial of CGuard EPS, that evaluated the peri-procedural and 30-day silent brain infarcts associated with the use of its ...
The CGuard® EPS Self-Expanding Carotid Stent is the latest generation open-cell nitinol self-expanding stent with patented MicroNet® mesh technology designed to prevent the risk of early and late embolism. “This milestone now provides physicians in France with the choice to use CGuard EPS in the treatment of ...
Our ultimate goal is to change the standard of care in the treatment of carotid artery disease away from surgical endarterectomy to the minimally invasive use of CGuard EPS Carotid Stent System. ...
(Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces the initiation of enrollment and successful completion of the first cases of the Company’s U.S. registration C-Guardian trial of CGuard EPS. The first patients, who were under ...
Nearly 20,000 patients were included (14,979 CEA and 4,993 TCAR) from the VQI CEA and carotid artery stent (CAS) registries over a 4-year time period (August 2016 to August 2020). ...
"Our customers have tested Digital SedationTM in some of their minimally invasive cardiovascular procedures (angioplasty, stenting, carotid, etc.), in the placement of catheters and implantable ports, and even in the administration of chemotherapy in day care. ...
He was right. Abbott acquired his firm, carotid stent specialist MedNova, in 2005. At the time, it was one of Ireland's biggest med tech success stories. ...